INTRODUCTION
============

Mitochondria are essential eukaryotic organelles that participate in a variety of cellular functions and play a central role in energy metabolism by producing adenosine triphosphate via the process of oxidative phosphorylation. Mitochondrial DNA (mtDNA) in mammals encodes thirteen critical oxidative phosphorylation components, as well as rRNAs and tRNAs required for mRNA translation by dedicated mitochondrial ribosomes in the matrix. Mitochondrial gene expression is a complex, multi-step process that requires a plethora of protein factors, all of which are encoded in the nucleus and imported into the organelle ([@gks1447-B1]). Transcription of mtDNA-encoded genes is carried out by a single-subunit, bacteriophage-related RNA polymerase, POLRMT ([@gks1447-B2]). Although the C-terminal catalytic domain of POLRMT shares significant sequence and structural homology with bacteriophage polymerases, the N-terminal extension is less conserved and, in mammalian mitochondrial RNA polymerases, contains two pentatricopeptide repeat (PPR) domains ([@gks1447-B3],[@gks1447-B5]). Studies in yeast show that the N-terminal extension of mtRNA polymerase is a binding platform for factors involved in coupling transcription to RNA processing and translation ([@gks1447-B5]). Although the function of the N-terminal extension in mammalian POLRMT remains to be determined and is not closely related in primary sequence to that of yeast, it seems reasonable to assume it too is involved in interactions that mediate additional functions of POLRMT beyond transcription.

Consistent with the structural differences between mitochondrial and bacteriophage RNA polymerases, the former requires additional transcription factors for initiation. In humans, two proteins, h-mtTFB1 and h-mtTFB2, were originally characterized as mitochondrial transcription initiation factors and both can support transcription initiation *in vitro* ([@gks1447-B10],[@gks1447-B11]). Interestingly, both h-mtTFB1 and h-mtTFB2 are homologous to the bacterial KsgA enzyme, a site-specific rRNA adenine *N*6-dimethyltransferase that dimethylates the small subunit rRNA in bacteria at a conserved stem--loop ([@gks1447-B12]). Although both h-mtTFB1 and h-mtTFB2 interact directly with POLRMT and cooperatively regulate mitochondrial gene expression and biogenesis ([@gks1447-B10],[@gks1447-B11]), their functions have diverged, with h-mtTFB2 being the primary mitochondrial transcription initiation factor and h-mtTFB1 being the primary 12S rRNA methyltransferase required for the biogenesis of the mammalian 28S mitochondrial ribosomal subunit ([@gks1447-B15]). Although the significance of the POLRMT--h-mtTFB2 interaction during transcription initiation is clear, the relevance of the POLRMT--h-mtTFB1 interaction *in vivo* ([@gks1447-B11]) has not been established.

Mammalian mtDNA is transcribed as polycistronic transcripts that undergo extensive processing before the liberated mRNAs are translated by a dedicated set of 55S mitochondrial ribosomes ([@gks1447-B1]). Although the two rRNAs (12S and 16S) are mtDNA- encoded, all mitochondrial ribosomal proteins (MRPs) are encoded in the nucleus and imported into mitochondria, where they assemble into the small (28S) and large (39S) mitochondrial ribosomal subunits. MRPs are designated as part of the large or small subunit by the letters 'L' or 'S' followed by a number (e.g. MRPL12 or MRPS10). The biogenesis and assembly pathways of mitochondrial ribosomes in mammalian mitochondria have not been characterized fully. Furthermore, steps involved in the final maturation of the small and large ribosomal subunits and checkpoint pathways that prevent association and translation initiation by immature ribosomes, which are operative in other systems ([@gks1447-B20],[@gks1447-B21]), have not been characterized in detail for mitochondrial ribosomes. Here, we report that human POLRMT, along with h-mtTFB1, associates stably with 28S mitochondrial ribosomes independently of its role in transcription, implicating it as a new factor required for mitochondrial ribosome biogenesis and function.

MATERIALS AND METHODS
=====================

Cells and antibodies
--------------------

HeLa cells expressing hemagglutinin-tagged POLRMT (HA-POLRMT), as well as MRPS10 and MRPL12 knockdown HeLa cells were generated as described previously ([@gks1447-B22]). ND6, MRPS10, MRPL37 and MRPL45 antibodies were purchased from Sigma. MRPS17, MRPS18B, MRPS27, MRPL12, MRPL13 and MRPL48 antibodies were purchased from ProteinTech Group. The h-mtTFB1 and h-mtTFB2 rabbit polyclonal antibodies were provided by Dr Craig Cameron. POLRMT antibody was purchased from Abcam; NDUFA9 and COII antibodies were obtained from Mitosciences.

Cross-linking, whole-cell extract preparation, immunoprecipitation and western blotting
---------------------------------------------------------------------------------------

Cellular proteins were cross-linked with dithiobis succinimidyl propionate (DSP) (Thermo Scientific) for 30 min as described previously ([@gks1447-B22]). Preparation of whole-cell extracts (WCE) and the immunoprecipitation (IP) conditions were also performed as described ([@gks1447-B22]). Briefly, cells were lysed in WCE buffer \[40 mM Tris--HCl pH 7.5, 150 mM NaCl, 10 mM MgCl~2~, 1 mM ethylenediaminetetraacetic acid, 1% NP40, 1× protease inhibitor cocktail (Roche)\], and 1--2 mg of total protein was used for IP with antibodies and protein G agarose (Pierce). After overnight incubation at 4°C, beads were washed four times with WCE buffer and co-precipitated proteins analysed by western blotting. Western blotting was carried out as described ([@gks1447-B22]). It is noted that 'inputs' shown in the figures are included only to demonstrate the relative loading and that the antibodies worked in the western blots (especially in control cases where no co-IP is observed). The input protein concentration does not necessarily correspond to the protein concentration of the co-IP experiment; hence, the western signals in the co-IP lanes in the figures often do not reflect the actual fold-enrichment. The co-IP experiments are, therefore, only interpreted as a qualitative measure of an interaction.

Sucrose density gradient fractionation
--------------------------------------

Linear sucrose gradients (10--30%) were prepared in 14 × 89 mm Beckman centrifuge tubes in the buffer described in ([@gks1447-B23]). Protein (3--10 mg) from whole-cell extracts was used for density centrifugation for 17.5 h at 80 000*g* in a Beckman L8-M ultracentrifuge. Fractions (1 ml) were collected from top to bottom and analysed by western blotting or diluted 1:3 in WCE buffer and used for IP as described previously ([@gks1447-B22]).

Quantitative reverse transcriptase-polymerase chain reaction and ethidium bromide treatment
-------------------------------------------------------------------------------------------

To inhibit mitochondrial transcription, cells were treated with 0.04 µg of ethidium bromide (EtBr) per 1 ml of media for 3 h. Cells were then washed twice with phosphate-buffered saline and harvested for total cellular RNA extraction. High Capacity cDNA Reverse Transcription kit (Applied Biosystems) was used for reverse transcription of 1.5--2 µg of total cellular RNA. Steady-state levels of mitochondrial transcripts were measured as described previously ([@gks1447-B22]). Quantitative polymerase chain reaction (PCR) results were analysed by unpaired two-tailed student's *t*-test.

Mitochondrial 12S rRNA methylation and respiration assays
---------------------------------------------------------

The 12S rRNA methylation-sensitive primer extension assay was performed as described previously ([@gks1447-B15]). Mitochondrial oxygen consumption rates were measured using an YSI 5300A Biological Oxygen Monitor. Cells were resuspended in respiration buffer (25 mM glucose, 1 mM pyruvate in phosphate-buffered saline), and oxygen consumption was recorded for 8 min, normalized to total cell protein, and plotted as the percent O~2~ consumed/s/mg protein in [Figure 5](#gks1447-F5){ref-type="fig"}B.

RESULTS
=======

Human mitochondrial RNA polymerase is associated with small mitochondrial ribosome subunit complexes containing the mitochondrial 12S rRNA methyltransferase h-mtTFB1
---------------------------------------------------------------------------------------------------------------------------------------------------------------------

Human mitochondrial RNA polymerase, POLRMT, binds directly to both h-mtTFB1 and h-mtTFB2 ([@gks1447-B10]). The POLRMT--h-mtTFB2 complex is generally accepted to be the primary complex involved in transcription initiation, but the nature and relevance of the POLRMT--h-mtTFB1 complex has not been established. To address this issue, we used a co-IP strategy with h-mtTFB1 and h-mtTFB2 to better define POLRMT complexes in HeLa cells. We found that POLRMT was able to efficiently co-IP with both h-mtTFB1 and h-mtTFB2 ([Figure 1](#gks1447-F1){ref-type="fig"}, lanes 3 and 4). However, h-mtTFB1 did not co-IP with h-mtTFB2 or vice versa, indicating that POLRMT forms separate complexes with each of these proteins. Although both h-mtTFB1 and h-mtTFB2 are related to rRNA methyltransferases ([@gks1447-B10]), h-mtTFB1 is the primary mitochondrial 12S rRNA methyltransferase in mammalian cells and required for 28S mitochondrial ribosomal subunit biogenesis ([@gks1447-B13],[@gks1447-B15]). We, therefore, considered that POLRMT might be associating with h-mtTFB1 in this context. Consistent with this hypothesis, we found that, in addition to POLRMT, proteins of the small mitochondrial ribosomal subunit were indeed co-precipitated with h-mtTFB1 ([Figure 1](#gks1447-F1){ref-type="fig"}A, lane 3). Large subunit mitochondrial ribosomal proteins did not co-IP with h-mtTFB1 ([Figure 1](#gks1447-F1){ref-type="fig"}A, lane 3), and no mitochondrial ribosomal proteins were co-immunoprecipitated with h-mtTFB2 ([Figure 1](#gks1447-F1){ref-type="fig"}A, lane 4). The specificity of these interactions was demonstrated by probing for two abundant mitochondrial proteins, heat shock protein 60 (HSP60) and NDUFA1, as negative controls, neither of which was co-immunoprecipitated with h-mtTFB1 or h-mtTFB2. Figure 1.POLRMT associates independently with both h-mtTFB2 and h-mtTFB1, as well as with small mitochondrial ribosomal subunit MRPs. (**A**) Western blot analysis of proteins co-precipitated with h-mtTFB1 (B1 IP) and h-mtTFB2 (B2 IP) from whole-cell HeLa extracts. (**B**) Immunoblotting of proteins co-immunoprecipitated with MRPS17 and MRPS18B from HeLa whole-cell extracts with and without DSP cross-linking (+/− DSP). IgG IP was used as a negative control. Antibodies used for analysis of input and immunoprecipitates are indicated. (**C**) Western blot analysis of proteins recovered in HA antibody IP from HeLa cell expressing HA-tagged POLRMT (HA) or empty vector as a negative control (C). Antibodies used for immunoblotting of input and pull-down fractions are shown.

To confirm association of POLRMT with small mitochondrial ribosomal subunits, we next performed co-IP experiments with the small mitochondrial proteins, MRPS17 and MRPS18B, in the presence or absence of DSP cross-linking to better trap transient interactions ([Figure 1](#gks1447-F1){ref-type="fig"}B). A significant amount of POLRMT was pulled down with MRPS17 and MRPS18B that also each co-IP other small ribosomal proteins ([Figure 1](#gks1447-F1){ref-type="fig"}B). Likewise, h-mtTFB1 was co-immunoprecipitated with both MRPS17 and MRPS18B, consistent with its specific interaction with 28S mitochondrial ribosomes ([@gks1447-B17]). However, h-mtTFB2 did not efficiently co-IP with these small mitochondrial ribosomal proteins (i.e. only a small amount was detected in cross-linked extracts) and, therefore, was not considered significant compared with the strong interactions of POLRMT and h-mtTFB1 with 28S subunits observed in the absence of cross-linking. The specificity of these co-IP experiments was confirmed using an IgG as a negative control, which did not pull down any proteins, and by the fact that other abundant mitochondrial (HSP60 and NDUF9) and cytoplasmic (tubulin) proteins did not co-IP with any of these three MRPs even after cross-linking with DSP ([Figure 1](#gks1447-F1){ref-type="fig"}B).

We next performed the reciprocal experiment using POLRMT for IP and analysis of co-precipitated proteins. As none of the available antibodies against endogenous POLRMT that we tested were able to immunoprecipitate the protein, we used HeLa cells that overexpress hemagglutinin-tagged POLRMT (HA-POLRMT) described previously ([@gks1447-B22]). When HA antibodies were used to immunoprecipitate HA-POLRMT (with or without DSP cross-linking), in addition to detecting the expected interaction with h-mtTFB2 (i.e. transcription complexes), multiple small subunit MRPs were co-immunoprecipitated from HA-POLRMT-expressing cells but not empty-vector control cells ([Figure 1](#gks1447-F1){ref-type="fig"}C), consistent with POLRMT interacting with small mitochondrial ribosomes. Importantly, similar results were obtained when sucrose gradients were performed on purified mitochondrial lysates from HA-POLRMT expressing HeLa cells ([Supplementary Figure S1A](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1)). Thus, the interactions observed are not an artefact of using whole-cell lysates. Altogether, these data show that POLRMT interacts with small mitochondrial ribosomes along with its known direct-binding partner h-mtTFB1 ([@gks1447-B10],[@gks1447-B11],[@gks1447-B24]).

Human mitochondrial RNA polymerase--ribosome complexes are distinct from those involved in transcription
--------------------------------------------------------------------------------------------------------

If POLRMT, like h-mtTFB1, stably associates with small mitochondrial ribosome subunits, we predicted they would co-fractionate in sucrose gradients. To this end, we used sucrose gradient sedimentation of HA-POLRMT-expressing HeLa extracts (post--DSP-cross-linking), followed by co-IP analysis of small mitochondrial ribosome complex-containing fractions to test for interaction with POLRMT. Based on western blot analysis of sucrose gradient fractions with multiple small and large subunit mitochondrial ribosomal proteins ([Figure 2](#gks1447-F2){ref-type="fig"}A), we were routinely able to isolate fractions that contained only small ribosomal subunit complexes (e.g. fraction 7 in [Figure 2](#gks1447-F2){ref-type="fig"}A). That such fractions contained only small mitochondrial subunits was confirmed by co-IPs with MRPS18B, which pulled down other small subunit MRPs, but not any large subunit ribosomal proteins tested ([Figure 2](#gks1447-F2){ref-type="fig"}B, lane 3). Consistent with our initial, unfractionated co-IP experiments ([Figure 1](#gks1447-F1){ref-type="fig"}B), MRPS18B also co-immunoprecipitated POLRMT ([Figure 2](#gks1447-F2){ref-type="fig"}B, lane 3), clearly demonstrating that POLRMT interacts and co-fractionates with small mitochondrial ribosomal subunits. Similar results were obtained with endogenous POLRMT protein in HeLa cells that do not overexpress POLRMT ([Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1)). Altogether, these data demonstrate that POLRMT physically associates with 28S mitochondrial ribosomes at some point during or after assembly in human mitochondria. Figure 2.POLRMT interacts with h-mtTFB1 in conjunction with small mitochondrial ribosome subunits. (**A**) Western blot analysis of 10--30% sucrose gradient sedimentation fractions used for immunoprecipitation in (**B**). HA-POLRMT HeLa cells were cross-linked with DSP before lysis and sucrose density sedimentation. Fractions numbers and antibodies used for analysis are shown. (B) Western blot analysis of proteins co-immunoprecipitated with MRPS18B (S18 IP) from sucrose gradient fraction number 7. (**C**) Immunoblotting of proteins recovered in IP with HA antibody (HA IP) from multiple sucrose fractions as indicated (Fr.2--Fr.8). Antibodies used for immunoblotting of co-precipitated proteins are shown. IP with no antibody added (No Ab IP) was used as a negative control. In (B and C), indicated fractions from (A) were used for immunoprecipitation.

We next performed co-IPs with POLRMT from multiple fractions of sucrose gradients to address the relationship between the POLRMT--ribosome--h-mtTFB1 complexes we identified herein to those involved in transcription. Confirming the results in [Figure 2](#gks1447-F2){ref-type="fig"}B, POLRMT co-precipitated h-mtTFB1 along with small subunit MRPs only in higher-density fractions containing small mitochondrial ribosomes ([Figure 2](#gks1447-F2){ref-type="fig"}C, fractions 7 and 8), consistent with a primary role of h-mtTFB1 in the biogenesis of the small ribosomal subunit and h-mtTFB1 and POLRMT interacting in this context. In contrast, h-mtTFB2 and free (non-ribosome associated) MRPL12, which both directly interact with POLRMT in transcription complexes ([@gks1447-B10],[@gks1447-B22],[@gks1447-B25]), were associated with POLRMT only in lower-density fractions that do not contain mitochondrial ribosomes ([Figure 2](#gks1447-F2){ref-type="fig"}C, fractions 3--5). These data confirm that POLRMT forms ribosome-associated complexes with h-mtTFB1 that are distinct from transcription-associated protein complexes with h-mtTFB2 and 'free' MRPL12 ([@gks1447-B22]).

Interaction of human RNA polymerase with small mitochondrial ribosomes occurs in the absence of active transcription
--------------------------------------------------------------------------------------------------------------------

We next investigated whether the interactions between POLRMT and small mitochondrial ribosomes depends on active transcription by exposing cells to a low dosage of EtBr to inhibit mitochondrial transcription, without interfering with mitochondrial ribosome assembly or stability ([@gks1447-B26]). As expected, steady-state levels of mitochondrial transcripts decreased in a time-dependent manner after drug treatment in HeLa cells expressing HA-tagged POLRMT or containing just an empty vector ([Figure 3](#gks1447-F3){ref-type="fig"}A). After 3 h of treatment, both mRNAs and rRNAs were significantly decreased, showing that transcription was successfully inhibited ([Figure 3](#gks1447-F3){ref-type="fig"}A). Therefore, at this time point, cells were lysed and used for co-IP experiments. All representative small subunit MRPs that we analysed were recovered in MRPS17 and MRPS18B co-IPs from EtBr-treated HeLa cells, confirming that 28S ribosomal subunits remained largely intact ([Figure 3](#gks1447-F3){ref-type="fig"}B). Similar amounts of endogenous POLRMT co-immunoprecipitated with MRPS17 or MRPS18B in the presence or absence of EtBr ([Figure 3](#gks1447-F3){ref-type="fig"}B). Likewise, in the reciprocal co-IP experiment, small mitochondrial ribosomes were similarly pulled down by HA antibodies in HA-POLRMT overexpressing cells in the presence and absence of EtBr ([Figure 3](#gks1447-F3){ref-type="fig"}C). These data show that the association of POLRMT with small mitochondrial ribosomes does not require active mitochondrial transcription. Figure 3.The interaction of POLRMT with small mitochondrial ribosomes occurs in the absence of active transcription. (**A**) Quantitative reverse transcriptase--PCR analysis of mitochondrial 12S and 16S rRNAs, and ND1 and COII mRNAs levels in EtBr-treated HeLa (left) and HA-POLRMT HeLa (right) cells. Time of EtBr treatment is indicated. For each transcript, the relative abundance at time zero is set to one. (**B**) Western blot analysis of MRPS17 (S17 IP) and MRPS18B (S18 IP) immunoprecipitates from HeLa cells with mitochondrial transcription inhibited by treatment with EtBr for 3 h. (**C**) Immunoblotting of proteins recovered in HA IP from empty vector control HeLa cells (Vector) or HA-POLRMT HeLa cells (HA-POLRMT) after 3 h EtBr treatment to inhibit mitochondrial transcription. In (B and C), antibodies used for detection are indicated on the right.

Human mitochondrial RNA polymerase facilitates 12S rRNA methylation by h-mtTFB1
-------------------------------------------------------------------------------

The transcription-independent co-association of POLRMT and h-mtTFB1 rRNA methyltransferase with small mitochondrial ribosomes led us to ascertain whether POLRMT can affect 12S rRNA methylation by h-mtTFB1. To do this, we again took advantage of HA-POLRMT overexpressing cells. In these cells, we found that the amount of 12S rRNA methylated at the specific stem--loop substrate by h-mtTFB1 was significantly increased ([Figure 4](#gks1447-F4){ref-type="fig"}A). This increase in methylation was not accompanied by an increase in the steady-state amount of h-mtTFB1 ([Figure 4](#gks1447-F4){ref-type="fig"}B) or an increase in its association with 28S mitochondrial ribosomes based on sucrose gradient fractionation ([Figure 4](#gks1447-F4){ref-type="fig"}C). There was also no change in the steady-state levels of mtDNA-encoded transcripts in response to POLRMT overexpression, including the 12S rRNA methylation substrate ([Figure 4](#gks1447-F4){ref-type="fig"}D). Altogether, these data indicate that POLRMT, through interaction with 28S mitochondrial ribosomes, enhances h-mtTFB1 enzymatic activity. Figure 4.Overexpression of POLRMT increases methylation of 12S rRNA by h-mtTFB1. (**A**) Quantification of methylation-specific primer extension analysis of mitochondrial 12S rRNA from control cells expressing empty vector (Ctrl) or cells overexpressing POLRMT (POLRMT OE). Shown is the methylated/unmethylated 12S rRNA ratio, which value in control cells was set to one. Mean ± standard deviation (*n* = 12) and *t*-test *P*-value are indicated. (**B**) Immunoblotting of indicated proteins in cells expressing empty vector (Ctrl) or overexpressing POLRMT (POLRMT OE). Duplicate samples were analysed (indicated by 1 and 2). (**C**) Western blot analysis of 10--30% sucrose density centrifugation fractions. Whole-cell extracts from empty vector control HeLa cells (vector) or HeLa cells overexpressing HA-POLRMT (POLRMT OE) were used for fractionation. Fractions numbers and fractions enriched for free MRPs and small (28S) mitochondrial ribosomes are indicated. h-mtTFB1 antibody was used for immunoblotting. (**D**) Steady-state levels of indicated mitochondrial transcripts in control (Ctrl) and POLRMT overexpression (OE) cells. Results from four biological replicates are shown (mean ± standard deviation). None of the transcripts analysed showed a statistically significant difference between wild-type cells and HA-POLRMT overexpressing cells.

Overexpression of human mitochondrial RNA polymerase perturbs mitochondrial ribosome assembly dynamics, and reduces mtDNA-encoded proteins and respiration
----------------------------------------------------------------------------------------------------------------------------------------------------------

The functional consequences of overexpressing human mitochondrial RNA polymerase have not been reported to date. This could in principle affect transcription, ribosome biogenesis (based on the results detailed so far) or both. To address this, we analysed further HeLa cells that overexpress HA-tagged POLRMT. As already shown, this does not result in changes in the steady-state levels of mtDNA-encoded transcripts ([Figure 4](#gks1447-F4){ref-type="fig"}D). However, it did result in a decrease in two mtDNA-encoded proteins (ND6 and COXII; [Figure 5](#gks1447-F5){ref-type="fig"}A), and a small, but significant, reduction in basal mitochondrial oxygen consumption ([Figure 5](#gks1447-F5){ref-type="fig"}B). This suggested to us that it is the function of POLRMT in ribosomes, rather than in transcription, that was driving these latter phenotypes. To test this hypothesis, we investigated mitochondrial ribosome assembly status using sucrose density centrifugation in cell overexpressing POLRMT. As shown in [Figure 5](#gks1447-F5){ref-type="fig"}D, we were able to successfully separate the 28S mitochondrial ribosomal subunits from larger mitochondrial ribosomal assemblies (likely 55S ribosomes and/or polysomes) in these gradients. Analysis of these gradients revealed that, although the steady-state level MRPs were largely unchanged ([Figure 5](#gks1447-F5){ref-type="fig"}C), there was a disruption in mitochondrial ribosome assembly dynamics in cells overexpressing POLRMT compared with empty-vector negative control cells ([Figure 5](#gks1447-F5){ref-type="fig"}D). Quantification of this ([Figure 5](#gks1447-F5){ref-type="fig"}D, graph below) and two other independent experiments ([Supplementary Figure S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1)) confirmed a significant decrease in the percentage of fully assembled mitochondrial ribosomes (i.e. less MRP signal in fraction 11, containing 55S and polysomes, versus lower-density fractions containing 28S and 39S subunits), suggesting that POLRMT negatively regulates 55S ribosome assembly (e.g. 28S/39S subunit joining) in human mitochondria. Figure 5.POLRMT overexpression reduces the steady-state level of mtDNA-encoded proteins and mitochondrial respiration, and it perturbs 28S ribosome assembly dynamics. (**A**) Western blot analysis of indicated proteins (right) in cells expressing empty vector (Ctrl) or overexpressing POLRMT (POLRMT OE). Changes in ND6 and COII proteins were quantified and graphed with the ratio of each to tubulin in control cells set to a value of 1.0 (the mean ± standard deviation is shown with *P*-values indicated). Duplicate samples were analysed (indicated by 1 and 2). (**B**) Basal (-rotenone) and rotenone-inhibited (+rotenone) mitochondrial oxygen consumption rates normalized to total protein in control (Ctrl, white bars) and POLRMT overexpressing (OE, grey bars) cells. The mean ± standard deviation (*n* = 12) is plotted with *P*-values indicated. (**C**) Western blot analysis of indicated MRPs in control (Ctrl) and POLRMT overexpressing (OE) cells. Duplicate samples were analysed (indicated by 1 and 2). (**D**) Western blot analysis of small and large subunit MRPs in 10--30% sucrose density centrifugation fractions. Whole-cell extracts from empty-vector control HeLa cells (Ctrl) or HeLa cells overexpressing HA-POLRMT (OE) were used for fractionation. Fractions 6 and 7, which are enriched for small mitochondrial subunits are labelled as 28S. Antibodies used for immunoblotting are shown on the right. As an approximation of degree of 55S mitochondrial ribosome assembly, the ratio of signal of indicated small subunit MRPs in the higher-density gradient fraction 11 (which likely contains 55S ribosomes and polysomes) to the total MRP signal in all ribosome-containing fractions (fractions 5--11) is plotted (% fully assembled). The average of results from this and two other independent experiments presented in [Supplementary Figure S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1) is graphed below (the mean ± standard deviation and *P*-values are indicated). In each experiment, the ratio for each MRP in control cells was set to one.

DISCUSSION
==========

The main conclusions we draw from the results of this study is that human mitochondrial RNA polymerase, POLRMT, has a transcription-independent role in the biogenesis and/or function of mitochondrial ribosomes that involves a physical and functional interaction with the h-mtTFB1 rRNA methyltransferase. Our interpretation of the specific results that lead to these conclusions is discussed later in the text. We also speculate on functions POLRMT may play in this previously unrecognized mitochondrial--ribosome context and the potential broader implications for RNA polymerase biology in terms of multi-functionality of these enzymes.

Our results provide multiple lines of evidence that POLRMT is stably associated with 28S mitochondrial ribosomes ([Figures 1](#gks1447-F1){ref-type="fig"}, [2](#gks1447-F2){ref-type="fig"}B and [3](#gks1447-F3){ref-type="fig"} and [Supplementary Figures S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1) and [S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1447/-/DC1)). These complexes also contain the 12S rRNA methyltransferase h-mtTFB1, but not its transcription initiation factor paralogue h-mtTFB2 or MRPL12, a protein of the large mitochondrial ribosome we showed previously binds directly to POLRMT in its 'free' form to activate transcription ([@gks1447-B22],[@gks1447-B25]). This separate pool of POLRMT being devoid of these transcription factors is also consistent with our results showing that its association with 28S mitochondrial ribosomes occurs independently of active transcription ([Figure 3](#gks1447-F3){ref-type="fig"}). We interpret these results to indicate that POLRMT forms multiple, distinct protein complexes that regulate different steps in mitochondrial gene expression, some of which are involved in transcription and some that are not. For example, h-mtTFB2 interacts with POLRMT in complexes that are devoid of mitochondrial ribosome components and h-mtTFB1 ([Figures 1](#gks1447-F1){ref-type="fig"}A and [2](#gks1447-F2){ref-type="fig"}C), which almost certainly are those involved in transcription initiation, whereas POLRMT and h-mtTFB1 are involved in separate 28S mitochondrial ribosome complexes that are involved in ribosome biogenesis and function independently of transcription. The full spectrum of POLRMT complexes, which will likely involve other factors functioning in transcriptional, co-transcriptional and post-transcriptional processes will be important to define going forward.

Potential functions of POLRMT in association with 28S mitochondrial ribosomes are worthy of discussion, and our study provides some important initial insight. First, the fact that POLRMT binds h-mtTFB1 directly ([@gks1447-B10]) and the POLRMT-28S mitochondrial ribosome complexes defined herein also contain h-mtTFB1, leads us to speculate that POLRMT and h-mtTFB1 are binding directly to each other in this context. That overexpression of POLRMT increases 12S rRNA methylation by h-mtTFB1 ([Figure 4](#gks1447-F4){ref-type="fig"}A) is consistent with these proteins interacting to modulate this methylation reaction. This seems to be a direct or indirect effect on enzymatic activity, as overexpression of POLRMT does not increase the steady-state amount or degree of small subunit association of h-mtTFB1 ([Figure 4](#gks1447-F4){ref-type="fig"}B--D). Although many possibilities exist to explain how POLRMT might modulate h-mtTFB1 methyltransferase activity, it is noteworthy that other site-specific RNA-modifying enzymes require protein co-factors or chaperones to target and modify their specific substrates. A salient example is the mitochondrial RNA methyltransferase NSUN4, which requires the mitochondrial transcription termination factor orthologue, MTERF4, to be targeted to its 16S rRNA substrate in the large mitochondrial ribosome subunit ([@gks1447-B27]). By analogy, we speculate that POLRMT is serving a similar function in the small mitochondrial ribosome subunit with regard to the h-mtTFB1 rRNA methyltransferase. It is tempting to speculate further that h-mtTFB1 and POLRMT together are part of a checkpoint pathway for 28S subunit assembly that prevents its binding to the 39S subunit before being fully formed, which if allowed to occur could lead to formation of defective 55S ribosomes and aberrant translation. A similar checkpoint function has been proposed for the bacterial rRNA methyltransferase, KsgA ([@gks1447-B28]), the homologue of h-mtTFB1, and for mouse mtTFB1 ([@gks1447-B17]), and it is consistent with data from bacteria that this methylation event occurs during small ribosome subunit assembly ([@gks1447-B28]). Therefore, we propose that 12S rRNA methylation occurs during the assembly of the human 28S mitochondrial ribosome, and that POLRMT both facilitates this reaction by h-mtTFB1 and then remains stably associated with the 28S ribosome to block its interaction with the 39S subunit until the 28S assembly is complete. Enhancing this 'blocking' function could explain the apparent disruption in 55S assembly we observe in cells overexpressing POLRMT ([Figure 5](#gks1447-F5){ref-type="fig"}D). It has been reported that a common polymorphism in the TFB1M gene (encoding h-mtTFB1) is associated with risk for type-2 diabetes ([@gks1447-B29]). This certainly increases the stake in understanding how this methylation event in mitochondria is regulated and causally involved in disease pathogenesis, and whether its interaction with POLRMT is important in this regard.

It is clear at this point that various steps of mitochondrial gene expression might be functionally and physically linked and tightly coordinated, as there are several examples of multi-functional mitochondrial factors involved in transcription initiation and downstream gene expression events. For example, members of mTERF family of transcription termination factors have been implicated in regulation of transcription initiation ([@gks1447-B30]), although their interaction with the core mitochondrial transcription machinery remains unclear. In addition, 'free' (non-ribosome associated) mitochondrial ribosomal protein MRPL12 selectively associates with POLRMT to modulate mitochondrial transcription, perhaps by facilitating the transition from initiation to elongation ([@gks1447-B22],[@gks1447-B25]). Finally, LRP130/LRPPRC, a PPR domains containing protein implicated in post-transcriptional processes, such as mitochondrial transcript stability, polyadenylation and translation ([@gks1447-B34]), also interacts with POLRMT and regulates mitochondrial transcription *in vitro* and *in vivo* ([@gks1447-B40],[@gks1447-B41]). Our study demonstrates that POLRMT is also a multi-functional protein and central to complex interactions between the mitochondrial transcription machinery, post-transcriptional processing factors and mitochondrial ribosomes, which will certainly be important to consider going forward in attempts to fully understand how mitochondrial gene expression is regulated in mammals and is involved in human disease and aging.

Finally, the elucidation of a transcription-independent role for mitochondrial RNA polymerase may have implications beyond the mitochondrial system. This may hold significance in bacteriophage systems, whose RNA polymerases are homologous to mitochondrial RNA polymerases ([@gks1447-B42]). Furthermore, the possibility that RNA polymerase may be involved in bacterial ribosome biogenesis via interaction with KsgA homologues seems likely based on the results of our study. Finally, ribosome biogenesis in eukaryotes occurs in the nucleolus and requires multiple RNA polymerases. We speculate that transcription-independent functions for these RNA polymerases may likewise exist to regulate the complex process of ribosome biogenesis.
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